Tag Archive for defective products

Revisiting the Chinese Drywall Crisis

5891937812_d1817d12b1_z

Since 2001, Chinese drywall has created problems for homeowners in the United States. A specific kind of drywall imported from China that contained sulfurous compounds left many people in a state of distress. From health complications to visible damage in household appliances made with copper and/or metal, the installation of Chinese drywall has proved to be disastrous. The sulfurous compounds contained in the drywall have been identified by The Consumer Product Safety Commission (CPSC); hydrogen sulfide, sulfur dioxide and carbon disulfide are just a few that have been found in the drywall testing.

The manufacturing of Chinese drywall consisting of sulfurous compounds has stopped since 2012 due to the Drywall Safety Act.

Most of the people affected by the negative side effects linked to contaminated Chinese drywall are located down south in states like Florida and Louisiana.

The hotter the air is, the more humid weather conditions are, which in turn causes the emission of said sulfurous compounds to be released from the drywall. When temperatures rise, the sulfurous compounds emit a rotten-egg like smell, and also corrode appliances like air conditioners and fire alarms causing appliances to fail and be replaced.

Though sometimes the sulfurous smell cannot be detected, it is still damaging to homeowners who are unaware of the complications that can arise from the defected Chinese drywall. Sulfurous compounds not only damage household appliances, but they also create serious health issues for people who are living in a house built with Chinese drywall. There have been reported complaints linked to homeowners living with Chinese drywall that include dry eye, headaches, sinus infections, nosebleeds and difficulty breathing.

Problems have and will keep arising if the Chinese drywall is not replaced.

In order to detect if you’re experiencing a Chinese drywall problem, a threshold inspection must take place. If the inspection validates that you’re indeed suffering from Chinese Drywall Syndrome, then legal action may be taken in order to receive compensation for any issues you’ve experienced while living with the defected Chinese drywall.

Photo Credit: Georgia National Guard, photo

Eliquis Leads to Deaths and Possible MDL Class Action Lawsuits

5750389070_7dee27a83d_z

Eliquis (Apixaban) is an oral anticoagulant made by Bristol-Myers Squibb and Pfizer. The blood thinning medication was first put on the market in 2012 in Europe, and was later approved by the FDA in the United States in 2014.  Before Eliquis was deemed safe enough to prescribe to patients, the drug went through a clinical trial under the name of ARISTOTLE. According to various news outlets, trial agents buried crucial information linked to the study from the FDA, like adverse side effects that transpired during the trial. Side effects included severe internal bleeding to subjects using the medication, and it was also noted that a death went unreported during the trial as well.

Eliquis proved to be more harmful than beneficial, but the drug went on the market nonetheless as Bristol-Meyers Squibb and Pfizer hid critical data about the adverse effects Eliquis had on its subjects during the trial.

The drug has only recently gained attention as a dangerous anticoagulant with two wrongful death claims reported within the past two years.

Other blood thinning medications like Xarelto (Rivaroxaban) and Pradaxa (Dabigatran) have caused problems and complications for patients before Eliquis was produced and manufactured.

Boehringer Ingelheim, Pradaxa’s manufacturer, paid $650 million dollars in 2014 to settle 4,000 state and federal lawsuits over their blood thinner Pradaxa.

It wasn’t until 2015 that a medication named Praxbind (Idarucizumab) was created to reverse the side effects associated with Pradaxa. And even so, Praxbind surfaced on the market too late as thousands of wrongful death lawsuits have been filed against Boehringer Ingelheim since 2012.

The recent lawsuits claims against Bristol-Meyers Squibb and Pfizer are centered on patients who have died from internal bleeding using Eliquis. A complaint was filed by Deborah Herschell for her husband’s death in June 2015. And in June of this year, another complaint was filed by Kathleen Odum for her father’s death in June 2014. Mr. Donald Herschell and Mr. Oliver Becker suffered from irregular heartbeat, or what is also known as atrial fibrillation (AFib). What both of these deaths have in common is that they were potentially caused by Eliquis.

What is AFib?

AFib is caused by an irregular, rapid heart rate that may cause poor blood flow to those who are diagnosed with the medical condition. Other symptoms of AFib include, but are not limited to:

  • Palpitations
  • Shortness of breath
  • Fatigue
  • Irregular blood supply
  • Blood clotting
  • Stroke
  • Heart Failure

Anticoagulants are therefore commonly prescribed to patients who suffer from AFib; they’re also prescribed to patients who undergo hip or knee replacement surgery to prevent blood clots from forming.

It’s unfortunate that these pharmaceutical corporations have failed to take responsibility for the health complications caused by the medications they supply. But there are many law firms willing to take on class action suits against Bristol-Meyers Squibb and Pfizer for their defected blood thinner medication, Eliquis. And while there aren’t enough Eliquis lawsuits for the courts to merge them into a multi-district litigation (MDL) just yet, plaintiffs’ lawyers expect more Eliquis claims to be filed across the country as the side effects of the drug worsen in patients.